Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunityMaorong Zhu, Huihui Ou, Zhengcong Cao et al.|Biochemical Pharmacology|2026Cited by 1
Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cellsMaorong Zhu, Zhengcong Cao, Yuxin Wu et al.|Journal of Nanobiotechnology|2026Cited by 0